Funded projects

• 

  Dr Daniel Conole

  University of Auckland

  

  Dr Amy Smith

  University of Auckland

  Project grant - $299,907 - Funding Round: 2026 A

  Genetic engineering of iPSCs for actionable drug target validation

  This project is using human brain immune cells to study a protein called GPNMB that is found at high levels in people with Alzheimer’s disease. Turning this protein on and off will show how it affects brain inflammation and cell damage. By understanding how GPNMB works, the team aim to uncover new ways to treat dementia.